Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium
- PMID: 23874912
- PMCID: PMC3715455
- DOI: 10.1371/journal.pone.0069196
Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium
Abstract
Life-threatening intestinal and systemic effects of the Shiga toxins produced by enterohemorrhagic Escherichia coli (EHEC) require toxin uptake and transcytosis across intestinal epithelial cells. We have recently demonstrated that EHEC infection of intestinal epithelial cells stimulates toxin macropinocytosis, an actin-dependent endocytic pathway. Host actin rearrangement necessary for EHEC attachment to enterocytes is mediated by the type 3 secretion system which functions as a molecular syringe to translocate bacterial effector proteins directly into host cells. Actin-dependent EHEC attachment also requires the outer membrane protein intimin, a major EHEC adhesin. Here, we investigate the role of type 3 secretion in actin turnover occurring during toxin macropinocytosis. Toxin macropinocytosis is independent of EHEC type 3 secretion and intimin attachment. EHEC soluble factors are sufficient to stimulate macropinocytosis and deliver toxin into enterocytes in vitro and in vivo; intact bacteria are not required. Intimin-negative enteroaggregative Escherichia coli (EAEC) O104:H4 robustly stimulate Shiga toxin macropinocytosis into intestinal epithelial cells. The apical macropinosomes formed in intestinal epithelial cells move through the cells and release their cargo at these cells' basolateral sides. Further analysis of EHEC secreted proteins shows that a serine protease EspP alone is able to stimulate host actin remodeling and toxin macropinocytosis. The observation that soluble factors, possibly serine proteases including EspP, from each of two genetically distinct toxin-producing strains, can stimulate Shiga toxin macropinocytosis and transcellular transcytosis alters current ideas concerning mechanisms whereby Shiga toxin interacts with human enterocytes. Mechanisms important for this macropinocytic pathway could suggest new potential therapeutic targets for Shiga toxin-induced disease.
Conflict of interest statement
Figures








Similar articles
-
Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells.Am J Physiol Cell Physiol. 2011 Nov;301(5):C1140-9. doi: 10.1152/ajpcell.00036.2011. Epub 2011 Aug 10. Am J Physiol Cell Physiol. 2011. PMID: 21832249 Free PMC article.
-
Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity.Appl Environ Microbiol. 2007 Oct;73(20):6351-9. doi: 10.1128/AEM.00920-07. Epub 2007 Aug 17. Appl Environ Microbiol. 2007. PMID: 17704265 Free PMC article.
-
Enterohemorrhagic E. coli (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers.Toxins (Basel). 2018 Sep 1;10(9):351. doi: 10.3390/toxins10090351. Toxins (Basel). 2018. PMID: 30200426 Free PMC article.
-
Escherichia coli O104:H4 Pathogenesis: an Enteroaggregative E. coli/Shiga Toxin-Producing E. coli Explosive Cocktail of High Virulence.Microbiol Spectr. 2014 Dec;2(6). doi: 10.1128/microbiolspec.EHEC-0008-2013. Microbiol Spectr. 2014. PMID: 26104460 Review.
-
Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence.Int J Med Microbiol. 2014 Jul;304(5-6):521-9. doi: 10.1016/j.ijmm.2014.05.005. Epub 2014 May 15. Int J Med Microbiol. 2014. PMID: 24933303 Review.
Cited by
-
Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria.BMC Microbiol. 2014 Jun 5;14:145. doi: 10.1186/1471-2180-14-145. BMC Microbiol. 2014. PMID: 24903402 Free PMC article.
-
Roles of Shiga Toxins in Immunopathology.Toxins (Basel). 2019 Apr 9;11(4):212. doi: 10.3390/toxins11040212. Toxins (Basel). 2019. PMID: 30970547 Free PMC article. Review.
-
BamA is required for autotransporter secretion.Biochim Biophys Acta Gen Subj. 2020 Jul;1864(7):129581. doi: 10.1016/j.bbagen.2020.129581. Epub 2020 Feb 27. Biochim Biophys Acta Gen Subj. 2020. PMID: 32114025 Free PMC article.
-
Transcriptomic and proteomic analysis of the virulence inducing effect of ciprofloxacin on enterohemorrhagic Escherichia coli.PLoS One. 2024 May 24;19(5):e0298746. doi: 10.1371/journal.pone.0298746. eCollection 2024. PLoS One. 2024. PMID: 38787890 Free PMC article.
-
Endocytosis, Cytotoxicity, and Translocation of Shiga Toxin-2 Are Stimulated by Infection of Human Intestinal (HCT-8) Monolayers With an Hypervirulent E. coli O157:H7 Lacking stx2 Gene.Front Cell Infect Microbiol. 2019 Nov 21;9:396. doi: 10.3389/fcimb.2019.00396. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31824869 Free PMC article.
References
-
- Serna A 4th, Boedeker EC (2008) Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 24: 38-47. doi:10.1097/MOG.0b013e3282f2dfb8. PubMed: 18043231. - DOI - PubMed
-
- Trachtman H, Austin C, Lewinski M, Stahl RA (2012) R e n a l a n d n e u r o l o g i c a l i n v o l v e m e n t in t y p i c a l S h i g a t o x i n - a s s o c i a t e d H U S . Nat Rev Nephrol 8(11):658-69 - PubMed
-
- Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086. doi:10.1016/S0140-6736(05)74232-X. PubMed: 15781103. - DOI - PubMed
-
- Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA (2011) Shiga toxin subtypes display dramatic differences in potency. Infect Immun 79(3): 1329-1337. doi:10.1128/IAI.01182-10. PubMed: 21199911. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases